| Q2 2024 |
25 |
$911M |
+$39.6M |
-$82M |
-$42.3M |
NUVL, NAMS, IRON, DNTH, PHVS
|
13F-HR |
8/12/2024, 01:30 PM |
| Q1 2024 |
26 |
$1.24B |
+$187M |
-$210M |
-$23.1M |
NAMS, NUVL, DNTH, IRON, KYTX
|
13F-HR |
5/15/2024, 01:00 PM |
| Q4 2023 |
27 |
$1.04B |
+$124M |
-$202M |
-$78.9M |
NUVL, NAMS, PHVS, IRON, MDGL
|
13F-HR |
2/13/2024, 04:30 PM |
| Q3 2023 |
31 |
$894M |
+$20.8M |
-$82.8M |
-$62M |
NUVL, PHVS, NAMS, SWTX, IRON
|
13F-HR |
11/14/2023, 04:00 PM |
| Q2 2023 |
32 |
$971M |
+$87.4M |
-$74.6M |
+$12.8M |
NUVL, NAMS, SWTX, PHVS, IRON
|
13F-HR |
8/14/2023, 04:31 PM |
| Q1 2023 |
34 |
$800M |
+$95.4M |
-$125M |
-$30M |
NAMS, NUVL, SWTX, IRON, NTRA
|
13F-HR |
5/15/2023, 04:12 PM |
| Q4 2022 |
33 |
$895M |
+$210M |
-$66.2M |
+$144M |
SWTX, NUVL, NAMS, NTRA, MRSN
|
13F-HR |
2/14/2023, 07:27 AM |
| Q3 2022 |
33 |
$838M |
+$58.4M |
-$84.9M |
-$26.6M |
SWTX, NUVL, MRSN, ARQT, DVAX
|
13F-HR |
11/14/2022, 04:00 PM |
| Q2 2022 |
35 |
$853M |
+$73.6M |
-$43.3M |
+$30.3M |
SWTX, DVAX, PHVS, ARQT, EQRX
|
13F-HR |
8/15/2022, 04:02 PM |
| Q1 2022 |
34 |
$1.03B |
+$61.2M |
-$5.38M |
+$55.8M |
SWTX, DVAX, ARQT, PHVS, RPID
|
13F-HR |
5/16/2022, 04:01 PM |
| Q4 2021 |
34 |
$1.26B |
+$141M |
-$79.4M |
+$62M |
SWTX, DVAX, RPID, ARQT, EQRX
|
13F-HR |
2/14/2022, 08:31 AM |
| Q3 2021 |
33 |
$1.61B |
+$369M |
-$229M |
+$140M |
SWTX, DVAX, RPID, AVIR, IVVD
|
13F-HR |
11/15/2021, 04:08 PM |
| Q2 2021 |
30 |
$1.53B |
+$50.1M |
-$57M |
-$6.93M |
SWTX, AVIR, DVAX, DRNA, ARQT
|
13F-HR |
8/16/2021, 04:23 PM |
| Q1 2021 |
31 |
$1.77B |
+$282M |
-$173M |
+$110M |
SWTX, AVIR, ARQT, DVAX, ANNX
|
13F-HR |
5/17/2021, 06:58 AM |
| Q4 2020 |
26 |
$1.59B |
+$450M |
-$169M |
+$282M |
SWTX, AVIR, ARQT, MRSN, ANNX
|
13F-HR |
2/16/2021, 06:13 AM |
| Q3 2020 |
21 |
$1.05B |
+$202M |
-$56.1M |
+$146M |
SWTX, ARQT, ANNX, DRNA, MRSN
|
13F-HR |
11/16/2020, 08:10 AM |
| Q2 2020 |
14 |
$932M |
+$164M |
-$41.5M |
+$123M |
SWTX, ARQT, DRNA, DVAX, MRSN
|
13F-HR |
8/14/2020, 08:05 AM |
| Q1 2020 |
10 |
$568M |
+$127M |
-$19.5M |
+$107M |
SWTX, ARQT, DRNA, CNST, DVAX
|
13F-HR |
5/15/2020, 08:00 AM |
| Q4 2019 |
10 |
$671M |
+$176M |
-$71.6M |
+$104M |
SWTX, CNST, DRNA, DVAX, REPL
|
13F-HR |
2/14/2020, 08:08 AM |
| Q3 2019 |
7 |
$388M |
+$208M |
$0 |
+$208M |
SWTX, DRNA, SLDB, REPL, DVAX
|
13F-HR |
11/14/2019, 08:32 AM |
| Q2 2019 |
5 |
$197M |
$0 |
-$52.9M |
-$52.9M |
DRNA, REPL, MRNS, SLDB, APTX
|
13F-HR |
8/14/2019, 09:01 AM |
| Q1 2019 |
6 |
$250M |
$0 |
-$39M |
-$39M |
DRNA, REPL, IFRX, MRNS, SLDB
|
13F-HR |
5/15/2019, 09:01 AM |
| Q4 2018 |
6 |
$293M |
+$3.06M |
$0 |
+$3.06M |
DRNA, IFRX, SLDB, APTX, REPL
|
13F-HR |
2/14/2019, 08:30 AM |
| Q3 2018 |
6 |
$441M |
+$45.7M |
$0 |
+$45.7M |
DRNA, SLDB, APTX, IFRX, REPL
|
13F-HR |
11/14/2018, 06:42 AM |
| Q2 2018 |
0 |
$0 |
$0 |
$0 |
|
|
13F-HR |
8/14/2018, 07:12 AM |
| Q1 2018 |
4 |
$170M |
+$14.9M |
$0 |
+$14.9M |
DRNA, IFRX, MRNS, SLDB
|
13F-HR |
5/15/2018, 07:28 AM |
| Q4 2017 |
3 |
$152M |
$0 |
$0 |
|
DRNA, IFRX, MRNS
|
13F-HR |
2/14/2018, 07:21 AM |